Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 3
2010 6
2011 7
2012 18
2013 17
2014 15
2015 17
2016 16
2017 8
2018 7
2019 6
2020 3
2021 6
2022 2
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Results by year

Filters applied: . Clear all
Page 1
Novel role of PKR in inflammasome activation and HMGB1 release.
Lu B, Nakamura T, Inouye K, Li J, Tang Y, Lundbäck P, Valdes-Ferrer SI, Olofsson PS, Kalb T, Roth J, Zou Y, Erlandsson-Harris H, Yang H, Ting JP, Wang H, Andersson U, Antoine DJ, Chavan SS, Hotamisligil GS, Tracey KJ. Lu B, et al. Nature. 2012 Aug 30;488(7413):670-4. doi: 10.1038/nature11290. Nature. 2012. PMID: 22801494 Free PMC article.
Safety pharmacology--current and emerging concepts.
Hamdam J, Sethu S, Smith T, Alfirevic A, Alhaidari M, Atkinson J, Ayala M, Box H, Cross M, Delaunois A, Dermody A, Govindappa K, Guillon JM, Jenkins R, Kenna G, Lemmer B, Meecham K, Olayanju A, Pestel S, Rothfuss A, Sidaway J, Sison-Young R, Smith E, Stebbings R, Tingle Y, Valentin JP, Williams A, Williams D, Park K, Goldring C. Hamdam J, et al. Toxicol Appl Pharmacol. 2013 Dec 1;273(2):229-41. doi: 10.1016/j.taap.2013.04.039. Epub 2013 Jun 1. Toxicol Appl Pharmacol. 2013. PMID: 23732082 Review.
Progress in pharmacogenetics: consortiums and new strategies.
Maroñas O, Latorre A, Dopazo J, Pirmohamed M, Rodríguez-Antona C, Siest G, Carracedo Á, LLerena A. Maroñas O, et al. Drug Metab Pers Ther. 2016 Mar;31(1):17-23. doi: 10.1515/dmpt-2015-0039. Drug Metab Pers Ther. 2016. PMID: 26913460 Free article. Review.
New uses for old drugs.
Pantziarka P, Pirmohamed M, Mirza N. Pantziarka P, et al. BMJ. 2018 Jun 26;361:k2701. doi: 10.1136/bmj.k2701. BMJ. 2018. PMID: 29945952 No abstract available.
Assessing the safety of stem cell therapeutics.
Goldring CE, Duffy PA, Benvenisty N, Andrews PW, Ben-David U, Eakins R, French N, Hanley NA, Kelly L, Kitteringham NR, Kurth J, Ladenheim D, Laverty H, McBlane J, Narayanan G, Patel S, Reinhardt J, Rossi A, Sharpe M, Park BK. Goldring CE, et al. Cell Stem Cell. 2011 Jun 3;8(6):618-28. doi: 10.1016/j.stem.2011.05.012. Cell Stem Cell. 2011. PMID: 21624806 Free article. Review.
Idiosyncratic adverse drug reactions: current concepts.
Uetrecht J, Naisbitt DJ. Uetrecht J, et al. Pharmacol Rev. 2013 Mar 8;65(2):779-808. doi: 10.1124/pr.113.007450. Print 2013 Apr. Pharmacol Rev. 2013. PMID: 23476052 Free PMC article. Review.
How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?
Laverty H, Benson C, Cartwright E, Cross M, Garland C, Hammond T, Holloway C, McMahon N, Milligan J, Park B, Pirmohamed M, Pollard C, Radford J, Roome N, Sager P, Singh S, Suter T, Suter W, Trafford A, Volders P, Wallis R, Weaver R, York M, Valentin J. Laverty H, et al. Br J Pharmacol. 2011 Jun;163(4):675-93. doi: 10.1111/j.1476-5381.2011.01255.x. Br J Pharmacol. 2011. PMID: 21306581 Free PMC article. Review.
122 results